Studies have shown that genetically engineered HCC cells expressing the sodium iodide symporter (NIS) protein can transfer NIS protein to other HCC cells in the form of EVs, exhibiting a high sensitivity to radiotherapy [136]. The gene discussed is SLC5A5; the disease is hepatocellular carcinoma.